Supplementary Table 2 from High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)